| Sample | Title | Value | Rank |
|---|
| GSM549121 | patient 080, normal, homogenized [OPG study] | 3.70395 | 8 |
| GSM549102 | patient 115, normal, homogenized [OPG study] | 3.94275 | 14 |
| GSM549104 | patient 119, normal, homogenized [OPG study] | 3.81748 | 12 |
| GSM549108 | patient 138, normal, homogenized [OPG study] | 4.01473 | 16 |
| GSM549119 | patient 077, normal, homogenized [OPG study] | 3.73878 | 9 |
| GSM549133 | patient 032, cancer, homogenized [OPG study] | 3.80235 | 12 |
| GSM549139 | patient 042, cancer, homogenized [OPG study] | 3.86107 | 13 |
| GSM549099 | patient 107, normal, homogenized [OPG study] | 3.86911 | 12 |
| GSM549109 | patient 139, normal, homogenized [OPG study] | 3.98245 | 15 |
| GSM549110 | patient 046, normal, homogenized [OPG study] | 3.86242 | 12 |
| GSM549114 | patient 063, normal, homogenized [OPG study] | 3.8315 | 12 |
| GSM549122 | patient 082, normal, homogenized [OPG study] | 3.94494 | 14 |
| GSM549134 | patient 033, cancer, homogenized [OPG study] | 3.89494 | 13 |
| GSM549136 | patient 036, cancer, homogenized [OPG study] | 3.83735 | 13 |
| GSM549140 | patient 044, cancer, homogenized [OPG study] | 3.86782 | 13 |
| GSM549111 | patient 047, normal, homogenized [OPG study] | 3.9045 | 14 |
| GSM549113 | patient 057, normal, homogenized [OPG study] | 3.77541 | 11 |
| GSM549132 | patient 031, cancer, homogenized [OPG study] | 3.56773 | 5 |
| GSM549137 | patient 038, cancer, homogenized [OPG study] | 4.09131 | 19 |
| GSM549142 | patient 047, cancer, homogenized [OPG study] | 3.70372 | 7 |
| GSM549100 | patient 110, normal, homogenized [OPG study] | 3.986 | 15 |
| GSM549107 | patient 135, normal, homogenized [OPG study] | 3.8043 | 11 |
| GSM549115 | patient 068, normal, homogenized [OPG study] | 4.24037 | 24 |
| GSM549116 | patient 072, normal, homogenized [OPG study] | 3.83927 | 12 |
| GSM549120 | patient 078, normal, homogenized [OPG study] | 3.67727 | 7 |
| GSM549131 | patient 030, cancer, homogenized [OPG study] | 3.67575 | 8 |
| GSM549118 | patient 074, normal, homogenized [OPG study] | 4.0631 | 18 |
| GSM549129 | patient 027, cancer, homogenized [OPG study] | 3.67727 | 7 |
| GSM549123 | patient 088, normal, homogenized [OPG study] | 3.79223 | 10 |
| GSM549124 | patient 006, cancer, homogenized [OPG study] | 3.98905 | 15 |
| GSM549126 | patient 015, cancer, homogenized [OPG study] | 3.80733 | 11 |
| GSM549128 | patient 025, cancer, homogenized [OPG study] | 3.72552 | 9 |
| GSM549103 | patient 117, normal, homogenized [OPG study] | 3.73845 | 8 |
| GSM549117 | patient 073, normal, homogenized [OPG study] | 3.83367 | 11 |
| GSM549138 | patient 041, cancer, homogenized [OPG study] | 3.95916 | 15 |
| GSM549141 | patient 045, cancer, homogenized [OPG study] | 3.94845 | 16 |
| GSM549130 | patient 028, cancer, homogenized [OPG study] | 3.77902 | 10 |
| GSM549101 | patient 111, normal, homogenized [OPG study] | 4.02144 | 17 |
| GSM549105 | patient 128, normal, homogenized [OPG study] | 3.79389 | 10 |
| GSM549106 | patient 134, normal, homogenized [OPG study] | 3.62081 | 7 |
| GSM549112 | patient 048, normal, homogenized [OPG study] | 4.0071 | 16 |
| GSM549125 | patient 011, cancer, homogenized [OPG study] | 3.69965 | 8 |
| GSM549127 | patient 024, cancer, homogenized [OPG study] | 3.77273 | 10 |
| GSM549135 | patient 035, cancer, homogenized [OPG study] | 3.82397 | 12 |